Literature DB >> 21389697

Indoxyl sulfate downregulates renal expression of Klotho through production of ROS and activation of nuclear factor-ĸB.

Hidehisa Shimizu1, Dilinaer Bolati, Ayinuer Adijiang, Yelixiati Adelibieke, Gulinuer Muteliefu, Atsushi Enomoto, Yukihiro Higashiyama, Yusuke Higuchi, Fuyuhiko Nishijima, Toshimitsu Niwa.   

Abstract

BACKGROUND/AIM: Klotho, an anti-aging gene, is expressed in the kidneys, and its renal expression is decreased in chronic kidney disease (CKD). The present study aimed to examine whether renal expression of Klotho is regulated by indoxyl sulfate, a uremic toxin, using rat kidneys and human proximal tubular cells (HK-2).
METHODS: The effect of indoxyl sulfate on renal expression of Klotho was examined using (1) Dahl salt-resistant normotensive rats (DN), (2) Dahl salt-resistant normotensive indoxyl sulfate-administered rats (DN+IS), (3) Dahl salt-sensitive hypertensive rats (DH), and (4) Dahl salt-sensitive hypertensive indoxyl sulfate-administered rats (DH+IS). The effects of indoxyl sulfate, inhibitors of nuclear factor-κB (NF-κB) and an antioxidant on the expression of Klotho in HK-2 cells were examined.
RESULTS: DH+IS and DN+IS rats showed decreased expression of Klotho mRNA in the kidneys as compared with DH and DN rats, respectively. Indoxyl sulfate suppressed the expression of Klotho mRNA and protein in HK-2 cells, whereas an antioxidant, N-acetylcysteine, and NF-κB inhibitors, pyrrolidine dithiocarbamate and isohelenin, alleviated these effects.
CONCLUSIONS: Indoxyl sulfate downregulates Klotho expression in kidneys through production of reactive oxygen species and activation of NF-κB in proximal tubular cells. Indoxyl sulfate may be involved in reduced renal expression of Klotho in CKD.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21389697     DOI: 10.1159/000324885

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  24 in total

1.  A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction.

Authors:  Ran-Hui Cha; Shin Wook Kang; Cheol Whee Park; Dae Ryong Cha; Ki Young Na; Sung Gyun Kim; Sun Ae Yoon; Sang Youb Han; Jae Hyun Chang; Sue K Park; Chun Soo Lim; Yon Su Kim
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-09       Impact factor: 8.237

Review 2.  Klotho and chronic kidney disease.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Contrib Nephrol       Date:  2013-05-03       Impact factor: 1.580

Review 3.  Arterial calcification and bone physiology: role of the bone-vascular axis.

Authors:  Bithika Thompson; Dwight A Towler
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

Review 4.  Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins.

Authors:  Suree Lekawanvijit; Henry Krum
Journal:  J Physiol       Date:  2014-06-06       Impact factor: 5.182

Review 5.  The gut-kidney axis.

Authors:  Pieter Evenepoel; Ruben Poesen; Björn Meijers
Journal:  Pediatr Nephrol       Date:  2016-11-15       Impact factor: 3.714

Review 6.  Stop chronic kidney disease progression: Time is approaching.

Authors:  Usama Abdel Azim Sharaf El Din; Mona Mansour Salem; Dina Ossama Abdulazim
Journal:  World J Nephrol       Date:  2016-05-06

7.  Methionine restriction delays senescence and suppresses the senescence-associated secretory phenotype in the kidney through endogenous hydrogen sulfide.

Authors:  Si-Yang Wang; Wen-Juan Wang; Jie-Qiong Liu; Yu-Huan Song; Ping Li; Xue-Feng Sun; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Cell Cycle       Date:  2019-06-05       Impact factor: 4.534

Review 8.  Molecular basis of Klotho: from gene to function in aging.

Authors:  Yuechi Xu; Zhongjie Sun
Journal:  Endocr Rev       Date:  2015-02-19       Impact factor: 19.871

Review 9.  αKlotho and Chronic Kidney Disease.

Authors:  J A Neyra; M C Hu
Journal:  Vitam Horm       Date:  2016-03-24       Impact factor: 3.421

10.  Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB.

Authors:  Dilinaer Bolati; Hidehisa Shimizu; Maimaiti Yisireyili; Fuyuhiko Nishijima; Toshimitsu Niwa
Journal:  BMC Nephrol       Date:  2013-03-04       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.